10-Q: FONAR Q2 Earnings Show Mixed Results Amidst Go-Private Bid

FONAR Corporation reported increased revenues but decreased net income for the six months ended December 31, 2025, as a proposed going-private transaction by its CEO progresses.

Summary

• Total revenues increased to $51.6 million for the six months ended December 31, 2025, up from $49.9 million in the prior year period.
• Net income attributable to FONAR decreased to $4.3 million for the six months ended December 31, 2025, compared to $5.1 million in the same period last year.
• Operating income for the six-month period decreased to $6.2 million from $7.0 million in the prior year, primarily due to costs increasing at a higher rate than revenues.
• A proposed going-private transaction, led by CEO Timothy Damadian, offers $19.00 per share for Common Stock and Class B Common Stock, $6.34 for Class C Common Stock, and $10.50 for Class A Non-voting Preferred Stock.
• The company plans to open a new diagnostic imaging center on Long Island, New York, before the end of the calendar year, with an estimated cost of $900,000.
• A material weakness in internal controls over financial reporting related to logical access management continues to exist, with remediation efforts ongoing.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed filing with declining six-month profitability and ongoing internal control issues, overshadowed by the uncertainty and potential finality of the going-private transaction at a fixed price, which limits future upside for current public shareholders.

Positives

• Total revenues increased by 3.3% to $51.6 million for the six months ended December 31, 2025, compared to $49.9 million in the prior year.
• Operating income for the three months ended December 31, 2025, increased to $3.0 million from $2.4 million in the same period last year.
• Net income attributable to FONAR for the three months ended December 31, 2025, increased to $2.1 million from $2.0 million in the prior year.
• The aggregate number of scans performed by owned and managed sites increased to 109,952 from 106,168 in the first half of fiscal 2025, partly due to the absence of hurricane-related closures.
• Working capital increased to $129.4 million at December 31, 2025, from $127.5 million at June 30, 2025.
• Total liabilities decreased by 4.3% to $54.4 million at December 31, 2025, from $56.8 million at June 30, 2025.

Negatives

• Net income attributable to FONAR decreased to $4.3 million for the six months ended December 31, 2025, from $5.1 million in the prior year period.
• Operating income for the six months ended December 31, 2025, decreased to $6.2 million from $7.0 million in the prior year, as costs and expenses increased at a higher rate (5.9%) than revenues (3.3%).
• Cash and cash equivalents decreased from $56.3 million at June 30, 2025, to $53.0 million at December 31, 2025.
• Net cash provided by operating activities decreased significantly to $1.9 million for the six months ended December 31, 2025, from $3.9 million in the prior year.
• Patient fee revenue decreased by approximately $560,000 for the six months ended December 31, 2025, compared to the prior year.
• The manufacturing and servicing of medical equipment segment reported an operating loss of $(2.7) million for the six months ended December 31, 2025, a larger loss than the $(2.3) million in the prior year.
• The management of diagnostic imaging centers segment's operating income decreased to $8.9 million for the six months ended December 31, 2025, from $9.4 million in the prior year.

Risks

• Proposed New York Tort Reform: Governor Kathy Hochul proposed tort reform measures for the New York automotive insurance industry, similar to Florida's 2023 changes, which resulted in more unpaid bills, higher administrative costs, lower volume, and lower reimbursement rates.
• Reduced Reimbursement Rates: Lower reimbursement rates from Medicare, other government programs, and private insurance companies for scanning center services, coupled with inflation in material and labor costs, negatively impact profitability.
• Inflation: Increased costs for materials and labor make organic growth more difficult and extend the time for new centers to achieve profitability, potentially threatening current operations and future expansion.
• Cybersecurity Threats: Reliance on IT systems makes the company vulnerable to breaches, ransomware, and denial-of-service attacks, which could disrupt operations, incur significant response costs, and potentially exceed insurance coverage. A material weakness in internal controls over IT systems exists.
• Dependence on Referrals: Substantial revenue from diagnostic imaging services depends on patient referrals from unaffiliated physicians and third parties; a reduction in referrals would decrease net revenue and operating margins.
• Recent and Future Changes in Florida Insurance Law: Florida's 2023 Tort Reform Act negatively impacted diagnostic imaging facilities with more unpaid bills, higher administrative costs, lower volume, and lower reimbursement rates. Ongoing proposals to repeal Florida's no-fault insurance law could cause significant payment delays.
• Scanning Facility Competition: The diagnostic imaging services market is highly competitive, with competition from radiologists, hospitals, clinics, and other independent organizations, particularly in Florida.
• Pressure to Control Healthcare Costs: Health maintenance organizations and preferred provider organizations aim to control healthcare costs, potentially impacting utilization, pricing, and reimbursement rates for diagnostic imaging services.
• Eligibility Changes to Insurance Programs: Potential shifts to government payors or an increase in uninsured patients, or changes in private insurance plans increasing patient financial responsibility, could reduce reimbursement rates or increase uncollectible receivables.
• Demand for MRI Scanners: Reduced reimbursement rates negatively affect MRI scanner sales, leading to lower demand and potential pressure for lower prices, which could reduce economies of scale and profit margins.
• Manufacturing Competition: Competitors like General Electric, Siemens, Hitachi, and Phillips have significantly greater financial resources and production capacity, posing a challenge despite FONAR's unique Stand-Up MRI scanner.
• Other Changes in Domestic and Worldwide Economic Conditions: Adverse changes in general domestic and global economic conditions, including tariffs, recessions, credit market disruptions, and military conflicts, could affect workforce, liquidity, financial condition, revenues, and profitability.
• Merger Not Completed: The proposed going-private merger may not be completed, leading to stock price decline, increased litigation, adverse impact on relationships, inability to retain key personnel, and significant incurred expenses without benefit.
• Termination Fee: If the Merger Agreement is terminated under certain circumstances, the company may be obligated to pay a $450,000 termination fee to Parent.
• Uncertainties During Merger Pendency: Uncertainty about the merger's effect on employees, customers, and third parties may adversely affect business, results, and financial condition, diverting management attention and potentially impacting strategic initiatives due to interim operating covenants.
• Stockholder Litigation: The company is subject to litigation related to the merger (Bruce Taylor v. Fonar Corporation et al.) and may face additional litigation, which could be costly, prevent merger consummation, or distract management.
• Deterrence of Competing Acquirers: Provisions in the Merger Agreement, voting agreements, and statements by the Acquisition Group could deter alternative acquisition proposals or lead to lower offers.
• Financing Risk for Merger: Parent's financing commitments for the merger are subject to conditions, and there is a risk that financing may not be funded, potentially delaying or preventing completion, although the merger is not contingent on obtaining financing.

Future Outlook

The company intends to open an additional diagnostic imaging center on Long Island, New York, before the end of the calendar year, with expected costs of $400,000 for a new scanner and $500,000 for buildout. Management is committed to improving operating results and addressing challenges from legislative and regulatory requirements, including stagnant Medicare reimbursement rates and increasing operational costs. The proposed going-private transaction is expected to close no later than March 12, 2026, subject to various conditions.

Management Comments

• We attribute this increase [in scans] the absence of hurricane related closures that we experienced in the first quarter of 2025.
• The combination of our small increase in revenues along with our costs and expenses increasing at a larger rate caused our operating income to decrease to $6.2 million for the six months ended December 31, 2025 as compared to $7.0 million for the six months ended December 31, 2024.
• The ability of HMCA to maintain its profitability is principally due to HMCAs success in marketing the scanning services of the facilities managed or owned by HMCA, notwithstanding the decrease in reimbursement rates paid for MRI scans by insurers, Medicare and other government programs.
• The reductions in reimbursement rates are not unique to HMCA or HMCAs clients.
• The combination of increasing costs and stagnant reimbursement rates create operational challenges in maintaining our historic performance levels.
• We are committed to improving our operating results and dealing with the challenges posed by legislative and regulatory requirements.
• Economic uncertainty and lower reimbursement rates for MRI scans, have depressed the market for our MRI scanner products, notwithstanding our scanners unique technological capabilities (e.g., multi-positional scanning).
• Because of our ability to remotely monitor the performance of customers scanners on a daily basis and to detect and repair any irregularities before more serious and costly problems develop, we have been able to contain our costs of providing service.
• We believe that our existing cash balances, internal cash generating capabilities and ability to secure additional financing, if necessary, are sufficient to finance our capital expenditures and other operating activities for at least the next 12 months.
• The Company also believes that its business plan has been responsible for its profitability in the past ten consecutive fiscal years and first six months of fiscal 2026, and that its capital resources will be adequate to support operations through a year from the date of filing.

Industry Context

StockSavvy.ai notes that FONAR operates within a challenging healthcare environment characterized by declining MRI reimbursement rates from government and private insurers, a trend not unique to FONAR. The industry also faces increasing operational costs due to inflation in materials and labor, which is compressing margins for diagnostic imaging centers. Legislative changes, such as Florida's Tort Reform Act and proposed New York tort reforms, further complicate the landscape by potentially increasing unpaid bills and administrative burdens. The diagnostic imaging market remains highly competitive, with major players like General Electric, Siemens, Hitachi, and Phillips dominating the manufacturing segment, while local radiologists and hospitals compete in the service sector. Cybersecurity threats are an escalating concern across the healthcare industry, requiring significant investment in IT security.

Comparison to Industry Standards

• The company's experience with reduced reimbursement rates from Medicare, other government programs, and private insurance companies for MRI scans is noted as "not unique to HMCA or HMCAs clients," indicating a broader industry trend affecting all providers.
• The competitive landscape for MRI scanner manufacturing includes significantly larger players like General Electric, Siemens, Hitachi, and Phillips, which possess greater financial resources and production capacity compared to FONAR.
• The Florida market for diagnostic imaging services is described as experiencing a "high level of competition," which, combined with recent tort reform, creates a challenging environment for the company's owned and managed centers, suggesting performance in this region is benchmarked against a tough competitive set.

Management Changes

Corporate Governance

Legal Proceedings

• Bruce Taylor v. Fonar Corporation et al., C.A. No. 2026-0142-JTL (Del. Ch.), filed February 2, 2026. The complaint alleges that the Merger is subject to Section 203 of the Delaware General Corporation Law's supermajority voting requirement due to prior agreements among certain FONAR stockholders. It seeks an order declaring the supermajority requirement, enjoining the vote until stockholders are informed, and a finding that the Board breached fiduciary duties. FONAR disputes these allegations.

Related Party Transactions

• Tallahassee Magnetic Resonance Imaging, Inc., Stand Up MRI of Boca Raton, Inc., and Stand Up MRI & Diagnostic Center, Inc. (related medical practices) have a guaranty agreement for management fees payable to the Company. Net revenues owed were $9,951,000 as of December 31, 2025.
• Bensonhurst MRI Limited Partnership, in which the CEO and President holds an interest, has agreements for service and maintenance of MRI scanners. The Company recorded $90,000 in service and repair fees and charged $301,000 for reimbursable salaries and marketing expenses for the six months ended December 31, 2025.
• Integrity Healthcare Management, LLC, owned by the CEO and President, holds a 7.1% interest in HMCA's Class A membership and receives distributions.
• Radian Healthcare Management, LLC, owned by the CEO and President's son-in-law, provided personnel recruitment services to the Company for approximately $99,000 for the six months ended December 31, 2025.
• Magnetic Resonance Management, LLC (MRM), owned by the CEO and President, purchased an MRI scanner from the Company for $577,000 via a promissory note (9% interest, due December 2028). The Company recorded $25,000 in investment income from this note for the six months ended December 31, 2025.
• Special one-time cash fees were paid to disinterested directors for their service on the Special Committee related to the merger: Rick Turk received $200,000 as Chair, and Robert Carrino received $175,000. These fees were paid in six equal monthly installments from July to December 2025 and were not contingent on the merger's consummation.

Stakeholder Impact

• Shareholders (Unaffiliated): Will receive a fixed cash price per share ($19.00 for Common/Class B, $6.34 for Class C, $10.50 for Class A Preferred) if the merger is completed, losing future equity upside. They face risks if the merger fails, including potential stock price decline and litigation costs.
• Shareholders (Acquisition Group): Will contribute their shares to Parent in exchange for membership units, maintaining an indirect ownership interest in the surviving private entity and benefiting from future earnings and growth.
• Employees: Key personnel retention is a concern during the merger's pendency. The CEO and COO are expected to continue in their roles post-merger.
• Customers: Business relationships with customers may be adversely impacted by uncertainties surrounding the merger. The company aims to continue providing enhanced equipment service and maintenance.
• Suppliers: Business relationships with suppliers may be adversely impacted by uncertainties surrounding the merger.
• Creditors: The company's liquidity and capital resources are believed to be sufficient, with financing commitments secured for the merger.

Next Steps

• Stockholders to vote on the adoption of the Merger Agreement at a Special Meeting, requiring both Company Stockholder Approval and Disinterested Stockholder Approval.
• Expiration or termination of any applicable waiting periods for the merger.
• Receipt of all necessary governmental consents, approvals, and authorizations for the merger.
• Remediation of the material weakness in internal controls over financial reporting, specifically enhancing risk assessment, implementing new user authentication, and new monitoring controls for system access.
• Opening of an additional diagnostic imaging center on Long Island, New York, before the end of the calendar year.
• Resolution of the stockholder class action complaint (Bruce Taylor v. Fonar Corporation et al.) challenging the merger's voting requirements.

Key Dates

Recommendation

The proposed going-private transaction at a fixed price of $19.00 per common share creates a ceiling for the stock's near-term appreciation. While the company shows some revenue growth and profitability in the short term, the six-month results indicate declining operating and net income, coupled with ongoing internal control weaknesses and significant industry headwinds like reduced reimbursement rates and increased costs. The pending litigation and the inherent risks of a merger not closing also add uncertainty. For existing shareholders, holding until the merger's outcome is clear seems prudent, as the fixed offer price limits upside, but the downside risk if the merger fails is substantial. New investors should exercise caution due to the limited upside potential and existing operational challenges.

Keywords

FONAR, 10-Q, Quarterly Report, MRI, Diagnostic Imaging, Healthcare Management, Going Private Transaction, Merger Agreement, Timothy Damadian, SEC Filing, Financial Results, Stock Repurchase, Internal Controls, Legal Proceedings, Reimbursement Rates, Tort Reform, Cybersecurity, Medical Equipment, NASDAQ